Challenges and strategies for the eradication of the HIV reservoir
- PMID: 27288651
- PMCID: PMC5086301
- DOI: 10.1016/j.coi.2016.05.015
Challenges and strategies for the eradication of the HIV reservoir
Abstract
Despite the success of highly active antiretroviral therapy (HAART) for inhibiting HIV replication and improving clinical outcomes, it fails to cure infection due to the existence of a stable latent proviral reservoir in memory CD4+ T cells. Because of the longevity of these cells harboring transcriptionally silent proviruses, devising strategies to induce viral gene expression so the host immune response can mediate clearance of the infected cells or the cells can undergo virus-induced cell death, has been of considerable recent interest. Here, we review current knowledge of latency, and the challenges to virus induction and eradication. Novel strategies to reactivate HIV reservoirs more effectively, in combination with immunotherapy, could lead to better clearance of the latent HIV reservoir.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
The forces driving clonal expansion of the HIV-1 latent reservoir.Virol J. 2020 Jan 7;17(1):4. doi: 10.1186/s12985-019-1276-8. Virol J. 2020. PMID: 31910871 Free PMC article. Review.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.Retrovirology. 2018 Feb 13;15(1):21. doi: 10.1186/s12977-018-0404-7. Retrovirology. 2018. PMID: 29433524 Free PMC article. Review.
-
The role of integration and clonal expansion in HIV infection: live long and prosper.Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8. Retrovirology. 2018. PMID: 30352600 Free PMC article. Review.
-
HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.Curr HIV Res. 2006 Apr;4(2):199-208. doi: 10.2174/157016206776055084. Curr HIV Res. 2006. PMID: 16611058 Review.
Cited by
-
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.Front Immunol. 2023 Nov 17;14:1270908. doi: 10.3389/fimmu.2023.1270908. eCollection 2023. Front Immunol. 2023. PMID: 38045703 Free PMC article.
-
Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1.RSC Adv. 2018 May 11;8(31):17279-17292. doi: 10.1039/c8ra01216d. eCollection 2018 May 9. RSC Adv. 2018. PMID: 35539279 Free PMC article.
-
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.J Pept Sci. 2019 Apr;25(4):e3155. doi: 10.1002/psc.3155. Epub 2019 Feb 27. J Pept Sci. 2019. PMID: 30809901 Free PMC article.
-
Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.Front Immunol. 2020 Mar 5;11:182. doi: 10.3389/fimmu.2020.00182. eCollection 2020. Front Immunol. 2020. PMID: 32194543 Free PMC article.
-
Identification, Localization, and Quantification of HIV Reservoirs Using Microscopy.Curr Protoc Cell Biol. 2019 Mar;82(1):e64. doi: 10.1002/cpcb.64. Epub 2018 Sep 28. Curr Protoc Cell Biol. 2019. PMID: 30265439 Free PMC article.
References
-
- Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol. 2009;7:798–812. - PubMed
-
- Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323:1304–1307. - PubMed
-
- Deeks SG. HIV: Shock and kill. Nature. 2012;487:439–440. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials